Sign up Australia
Proactive Investors - Run By Investors For Investors

1ST Group crosses major milestone in online appointment booking

Over 5 million appointments booked on the portal since 2012.
1ST Group crosses major milestone in online appointment booking
Recently signed an agreement with Mylan N.V.

1st Group (ASX:1ST) has crossed a major milestone by booking over 5 million appointments on its cloud-based online health portal since 2012.

The company’s secure portal enables patients to schedule appointments, receive automated appointment reminders and provide feedback to their practitioners.

The number of new patients using 1st Group’s appointment booking platform on a monthly basis has surged 700% since 2015.

Presently, almost 60% of all appointments on the platform are made during business hours, up from 48% just two years ago.

This validates 1st Group’s value proposition to practices of making reception desks more efficient, reducing practice administration costs and driving greater convenience for patients.

1ST Group’s first half of FY17 laid the foundations for a potentially stronger revenue and sales growth in the second half, securing major deals with Alphapharm and ProVision in Q2 2017.

Alphapharm, a wholly owned subsidiary of Mylan N.V., is one of the world's leading global pharmaceutical companies.

Customers of Alphapharm’s 410 stores will be able to use 1stAvailable portal and book online services such as flu shots, diabetes and other healthcare services.

There are significant growth opportunities in 2017, following the shift in consumer trends and increasing government initiatives in digitising healthcare such as the launch of the Australian Digital Health Agency in 2016.

1ST Group’s shares were last trading 4.26% higher intra-day on Monday, at $0.049.

View full 1ST profile View Profile

1st Group Ltd Timeline

Related Articles

Flow chart of the Hazer Process
March 21 2018
The Hazer Process could disrupt the $100 billion hydrogen production market.
ROBO Global US CEO Travis Briggs
Wed
Investors can buy directly into the popular ROBO ETF based on the benchmark index comprised of 87 top robotics, automation and AI companies.
Digital marketing
May 03 2018
Lots of marketing groups have pursued a 'buy and build' strategy and have become cumbersome as a result; Be Heard puts the emphasis on maintaining agility

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use